Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Clostridium difficile infection in the Lao People's Democratic Republic: first isolation and review of the literature.

Cheong E, Roberts T, Rattanavong S, Riley TV, Newton PN, Dance DAB.

BMC Infect Dis. 2017 Sep 21;17(1):635. doi: 10.1186/s12879-017-2737-6.

2.

Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009-2016) retrospective study in a large university hospital.

Xu Q, Chen Y, Gu S, Lv T, Zheng B, Shen P, Quan J, Fang Y, Li L.

Sci Rep. 2017 Aug 29;7(1):9645. doi: 10.1038/s41598-017-09961-0.

3.

Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals.

Delgado A, Reveles IA, Cabello FT, Reveles KR.

BMC Infect Dis. 2017 Jun 23;17(1):448. doi: 10.1186/s12879-017-2553-z.

4.

Clostridium difficile infection.

Geller SA, de Campos FPF.

Autops Case Rep. 2014 Jun 30;4(2):5-7. doi: 10.4322/acr.2014.015. eCollection 2014 Apr-Jun. No abstract available.

6.

Recurrent Clostridium difficile infection among Medicare patients in nursing homes: A population-based cohort study.

Zilberberg MD, Shorr AF, Jesdale WM, Tjia J, Lapane K.

Medicine (Baltimore). 2017 Mar;96(10):e6231. doi: 10.1097/MD.0000000000006231.

7.
8.

Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Fang FC, Polage CR, Wilcox MH.

J Clin Microbiol. 2017 Mar;55(3):670-680. doi: 10.1128/JCM.02463-16. Epub 2017 Jan 11.

9.

Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance.

Park L, Mone A, Price JC, Tzimas D, Hirsh J, Poles MA, Malter L, Chen LA.

Ann Gastroenterol. 2017;30(1):83-88. doi: 10.20524/aog.2016.0098. Epub 2016 Oct 20.

10.

Management of Clostridium difficile Infection.

Al-Jashaami LS, DuPont HL.

Gastroenterol Hepatol (N Y). 2016 Oct;12(10):609-616.

11.

Interspecies Interactions between Clostridium difficile and Candida albicans.

van Leeuwen PT, van der Peet JM, Bikker FJ, Hoogenkamp MA, Oliveira Paiva AM, Kostidis S, Mayboroda OA, Smits WK, Krom BP.

mSphere. 2016 Nov 9;1(6). pii: e00187-16. eCollection 2016 Nov-Dec.

12.

Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case report.

Minami K, Sakaguchi Y, Yoshida D, Yamamoto M, Ikebe M, Morita M, Toh Y.

Surg Case Rep. 2016 Dec;2(1):76. doi: 10.1186/s40792-016-0199-5. Epub 2016 Jul 28.

13.

Burden of Clostridium difficile Infections in Québec by Levy et al.

Longtin Y, Garenc C, Valiquette L.

Open Forum Infect Dis. 2016 Jul 1;3(3):ofw139. doi: 10.1093/ofid/ofw139. eCollection 2016 Sep. No abstract available.

14.

An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes.

Thabit AK, Nicolau DP.

Infect Drug Resist. 2016 Jun 27;9:143-8. doi: 10.2147/IDR.S108325. eCollection 2016.

15.

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.

Min JH, Kim YS.

Gut Liver. 2016 Jul 15;10(4):493-4. doi: 10.5009/gnl16216. No abstract available.

16.

Clinical characteristics of Clostridium difficile-associated diarrhea among patients in a tertiary care center in China.

Li Y, Huang Y, Li Y, Nie Y.

Pak J Med Sci. 2016 May-Jun;32(3):736-41. doi: 10.12669/pjms.323.9400.

17.

Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.

Lewis BB, Carter RA, Pamer EG.

Anaerobe. 2016 Oct;41:32-36. doi: 10.1016/j.anaerobe.2016.05.010. Epub 2016 May 27.

18.

The microbiota and immune response during Clostridium difficile infection.

Buonomo EL, Petri WA Jr.

Anaerobe. 2016 Oct;41:79-84. doi: 10.1016/j.anaerobe.2016.05.009. Epub 2016 May 20. Review.

19.

Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy.

Dos Santos-Schaller O, Boisset S, Seigneurin A, Epaulard O.

Springerplus. 2016 Apr 11;5:430. doi: 10.1186/s40064-016-2058-z. eCollection 2016.

20.

Fecal Transplantation using a Nasoenteric Tube during an Initial Episode of Severe Clostridium difficile Infection.

Jeon YD, Hong N, Kim JH, Park SH, Kim SB, Song IJ, Ann HW, Ahn JY, Kim SB, Ku NS, Lee K, Yong D, Kim JM, Choi JY.

Infect Chemother. 2016 Mar;48(1):31-5. doi: 10.3947/ic.2016.48.1.31. Epub 2016 Mar 31.

Supplemental Content

Support Center